Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial

Yuichi Esaki, Tsuyoshi Kitajima, Yasuhiro Ito, Shigefumi Koike, Yasumi Nakao, Akiko Tsuchiya, Marina Hirose, Nakao Iwata

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

It has been recently discovered that blue wavelengths form the portion of the visible electromagnetic spectrum that most potently regulates circadian rhythm. We investigated the effect of blue light-blocking glasses in subjects with delayed sleep phase disorder (DSPD). This open-label trial was conducted over 4 consecutive weeks. The DSPD patients were instructed to wear blue light-blocking amber glasses from 21:00 p.m. to bedtime, every evening for 2 weeks. To ascertain the outcome of this intervention, we measured dim light melatonin onset (DLMO) and actigraphic sleep data at baseline and after the treatment. Nine consecutive DSPD patients participated in this study. Most subjects could complete the treatment with the exception of one patient who hoped for changing to drug therapy before the treatment was completed. The patients who used amber lens showed an advance of 78 min in DLMO value, although the change was not statistically significant (p = 0.145). Nevertheless, the sleep onset time measured by actigraph was advanced by 132 min after the treatment (p = 0.034). These data suggest that wearing amber lenses may be an effective and safe intervention for the patients with DSPD. These findings also warrant replication in a larger patient cohort with controlled observations.

Original languageEnglish
Pages (from-to)1037-1044
Number of pages8
JournalChronobiology International
Volume33
Issue number8
DOIs
Publication statusPublished - 13-09-2016

Fingerprint

Circadian Rhythm
Glass
Amber
Light
Melatonin
Lenses
Sleep
Electromagnetic Phenomena
Therapeutics
Sleep Wake Disorders
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

Esaki, Yuichi ; Kitajima, Tsuyoshi ; Ito, Yasuhiro ; Koike, Shigefumi ; Nakao, Yasumi ; Tsuchiya, Akiko ; Hirose, Marina ; Iwata, Nakao. / Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder : An open-label trial. In: Chronobiology International. 2016 ; Vol. 33, No. 8. pp. 1037-1044.
@article{48718328f4d541a89e9ae0a4f5c28717,
title = "Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial",
abstract = "It has been recently discovered that blue wavelengths form the portion of the visible electromagnetic spectrum that most potently regulates circadian rhythm. We investigated the effect of blue light-blocking glasses in subjects with delayed sleep phase disorder (DSPD). This open-label trial was conducted over 4 consecutive weeks. The DSPD patients were instructed to wear blue light-blocking amber glasses from 21:00 p.m. to bedtime, every evening for 2 weeks. To ascertain the outcome of this intervention, we measured dim light melatonin onset (DLMO) and actigraphic sleep data at baseline and after the treatment. Nine consecutive DSPD patients participated in this study. Most subjects could complete the treatment with the exception of one patient who hoped for changing to drug therapy before the treatment was completed. The patients who used amber lens showed an advance of 78 min in DLMO value, although the change was not statistically significant (p = 0.145). Nevertheless, the sleep onset time measured by actigraph was advanced by 132 min after the treatment (p = 0.034). These data suggest that wearing amber lenses may be an effective and safe intervention for the patients with DSPD. These findings also warrant replication in a larger patient cohort with controlled observations.",
author = "Yuichi Esaki and Tsuyoshi Kitajima and Yasuhiro Ito and Shigefumi Koike and Yasumi Nakao and Akiko Tsuchiya and Marina Hirose and Nakao Iwata",
year = "2016",
month = "9",
day = "13",
doi = "10.1080/07420528.2016.1194289",
language = "English",
volume = "33",
pages = "1037--1044",
journal = "Chronobiology International",
issn = "0742-0528",
publisher = "Informa Healthcare",
number = "8",

}

Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder : An open-label trial. / Esaki, Yuichi; Kitajima, Tsuyoshi; Ito, Yasuhiro; Koike, Shigefumi; Nakao, Yasumi; Tsuchiya, Akiko; Hirose, Marina; Iwata, Nakao.

In: Chronobiology International, Vol. 33, No. 8, 13.09.2016, p. 1037-1044.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder

T2 - An open-label trial

AU - Esaki, Yuichi

AU - Kitajima, Tsuyoshi

AU - Ito, Yasuhiro

AU - Koike, Shigefumi

AU - Nakao, Yasumi

AU - Tsuchiya, Akiko

AU - Hirose, Marina

AU - Iwata, Nakao

PY - 2016/9/13

Y1 - 2016/9/13

N2 - It has been recently discovered that blue wavelengths form the portion of the visible electromagnetic spectrum that most potently regulates circadian rhythm. We investigated the effect of blue light-blocking glasses in subjects with delayed sleep phase disorder (DSPD). This open-label trial was conducted over 4 consecutive weeks. The DSPD patients were instructed to wear blue light-blocking amber glasses from 21:00 p.m. to bedtime, every evening for 2 weeks. To ascertain the outcome of this intervention, we measured dim light melatonin onset (DLMO) and actigraphic sleep data at baseline and after the treatment. Nine consecutive DSPD patients participated in this study. Most subjects could complete the treatment with the exception of one patient who hoped for changing to drug therapy before the treatment was completed. The patients who used amber lens showed an advance of 78 min in DLMO value, although the change was not statistically significant (p = 0.145). Nevertheless, the sleep onset time measured by actigraph was advanced by 132 min after the treatment (p = 0.034). These data suggest that wearing amber lenses may be an effective and safe intervention for the patients with DSPD. These findings also warrant replication in a larger patient cohort with controlled observations.

AB - It has been recently discovered that blue wavelengths form the portion of the visible electromagnetic spectrum that most potently regulates circadian rhythm. We investigated the effect of blue light-blocking glasses in subjects with delayed sleep phase disorder (DSPD). This open-label trial was conducted over 4 consecutive weeks. The DSPD patients were instructed to wear blue light-blocking amber glasses from 21:00 p.m. to bedtime, every evening for 2 weeks. To ascertain the outcome of this intervention, we measured dim light melatonin onset (DLMO) and actigraphic sleep data at baseline and after the treatment. Nine consecutive DSPD patients participated in this study. Most subjects could complete the treatment with the exception of one patient who hoped for changing to drug therapy before the treatment was completed. The patients who used amber lens showed an advance of 78 min in DLMO value, although the change was not statistically significant (p = 0.145). Nevertheless, the sleep onset time measured by actigraph was advanced by 132 min after the treatment (p = 0.034). These data suggest that wearing amber lenses may be an effective and safe intervention for the patients with DSPD. These findings also warrant replication in a larger patient cohort with controlled observations.

UR - http://www.scopus.com/inward/record.url?scp=84975230414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975230414&partnerID=8YFLogxK

U2 - 10.1080/07420528.2016.1194289

DO - 10.1080/07420528.2016.1194289

M3 - Article

C2 - 27322730

AN - SCOPUS:84975230414

VL - 33

SP - 1037

EP - 1044

JO - Chronobiology International

JF - Chronobiology International

SN - 0742-0528

IS - 8

ER -